Vildagliptin and biguanide on postprandial blood glucose and vascular endothelial function in type 2 diabetic patients with coronary artery disease
Latest Information Update: 16 May 2016
At a glance
- Drugs Biguanides (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms VIBRATE-J
- 30 Apr 2016 Status changed from recruiting to discontinued.
- 07 May 2013 New trial record